Arctic Sun Article Featured in European Resuscitation Council Journal

New study demonstrates trend of better performance with the Arctic Sun compared to standard methods of inducing therapeutic hypothermia.

LOUISVILLE, Colorado, January 5 - The European Resuscitation Council (ERC) and Elsevier's journal
Resuscitation chose a randomized controlled study demonstrating a trend
toward faster cooling and better control with Medivance's Arctic Sun(R)
Temperature Management System
(www.medivance.com/html/products_arcticsun.htm) as its featured
"Article of the Month." The article chosen for December 2009 and published in
the January 2010 edition is entitled, "A randomized controlled trial
comparing the Arctic Sun to standard cooling for induction of hypothermia
after cardiac arrest."

The study was conducted at five hospitals in the U.S. in 2004-2007 that
were among the first to implement the joint AHA/ERC guidelines for the
treatment of comatose patients after cardiac arrest. Sixty-four patients were
enrolled in the study and treated with post arrest cooling; approximately
half with standard methods supplemented with ice and the other half with the
Arctic Sun Temperature Management System alone.

"The article is a good source of information about the issues and
challenges often encountered by hospitals that are just beginning the process
of implementing a cooling program for post arrest patients," said Dr. Kennon
Heard, principal investigator and Associate Professor of Surgery and Medicine
at the University of Colorado School of Medicine. "Despite the steep learning
curve associated with new cooling procedures and the small sample size of the
study, the Arctic Sun was easy to use and showed a trend of faster cooling
and more precise temperature control than cooling blankets supplemented with
ice."

In addition, although the study was not powered for clinical outcomes,
the high proportion of patients with good neurological outcomes (CPC 1 or 2)
is similar to or better than other studies of controlled hypothermia," he
added.

"It is an honor for this study conducted with the Arctic Sun to be
featured by the journal Resuscitation," stated Robert Kline, President and
CEO of Medivance. "At the time the study was undertaken, Targeted Temperature
Management(TM) was not as widely implemented as today and the lessons learned
provide a good starting point for hospitals looking to start or improve their
own cooling programs."

Cooling a standard of care

Since 2005, when the American Heart Association (AHA) issued
recommendations and guidelines for inducing mild hypothermia in comatose
survivors of cardiac arrest, adoption of therapeutic cooling has been on the
rise. A rapidly growing body of medical literature suggests it may also
reduce damage resulting from refractory fevers and other critical illnesses
such as stroke and traumatic brain injury.

About Medivance's Arctic Sun

The noninvasive Arctic Sun Temperature Management System precisely
monitors and maintains core body temperature in a therapeutic range, between
32 degrees and 38.5 degrees Celsius (approximately 89.6 degrees to 101.3
degrees Fahrenheit) with the potential to minimize damage to the heart and
brain. The patented design of the Arctic Sun and ArcticGel(TM) Pads enables
the transfer of up to five times more thermal energy than conventional
products such as water blankets, wraps or ice packs, resulting in more
efficient temperature management. The system's precision also enables the
slow rewarming thought to be critical for therapeutic benefit. The Arctic Sun
has received 510(k) FDA clearance in the U.S., the European Union's CE Mark,
and marketing approval in Japan and other global markets. Medivance develops
and manufacturers proprietary Targeted Temperature Management solutions.

www.medivance.com

Edna Kaplan of KOGS Communication, +1-781-639-1910, office, or +1-617-974-8659, mobile, kaplan at kogspr.com; NOTE TO EDITORS: Photos available for download at www.medivance.com/html/multimedia_photos.htm